Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)

Chong Kun Dang Pharmaceutical Statistics

Total Valuation

Chong Kun Dang Pharmaceutical has a market cap or net worth of KRW 1.14 trillion. The enterprise value is 1.03 trillion.

Market Cap	1.14T
Enterprise Value	1.03T

Important Dates

The next estimated earnings date is Monday, February 3, 2025.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Chong Kun Dang Pharmaceutical has 12.62 million shares outstanding. The number of shares has decreased by -0.39% in one year.

Current Share Class	n/a
Shares Outstanding	12.62M
Shares Change (YoY)	-0.39%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	14.01%
Owned by Institutions (%)	23.30%
Float	7.45M

Valuation Ratios

The trailing PE ratio is 6.08.

PE Ratio	6.08
Forward PE	n/a
PS Ratio	0.69
PB Ratio	1.28
P/TBV Ratio	1.39
P/FCF Ratio	7.93
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.19, with an EV/FCF ratio of 7.12.

EV / Earnings	5.44
EV / Sales	0.61
EV / EBITDA	4.19
EV / EBIT	4.95
EV / FCF	7.12

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.24.

Current Ratio	2.54
Quick Ratio	1.63
Debt / Equity	0.24
Debt / EBITDA	0.88
Debt / FCF	1.49
Interest Coverage	24.01

Financial Efficiency

Return on equity (ROE) is 23.54% and return on invested capital (ROIC) is 12.55%.

Return on Equity (ROE)	23.54%
Return on Assets (ROA)	9.47%
Return on Capital (ROIC)	12.55%
Revenue Per Employee	736.24M
Profits Per Employee	83.06M
Employee Count	2,276
Asset Turnover	1.23
Inventory Turnover	3.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.95% in the last 52 weeks. The beta is 0.83, so Chong Kun Dang Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-25.95%
50-Day Moving Average	99,072.00
200-Day Moving Average	106,130.00
Relative Strength Index (RSI)	42.16
Average Volume (20 Days)	33,106

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chong Kun Dang Pharmaceutical had revenue of KRW 1.68 trillion and earned 189.04 billion in profits. Earnings per share was 14,919.38.

Revenue	1.68T
Gross Profit	634.60B
Operating Income	207.07B
Pretax Income	208.80B
Net Income	189.04B
EBITDA	244.88B
EBIT	207.07B
Earnings Per Share (EPS)	14,919.38

Balance Sheet

The company has 334.27 billion in cash and 215.04 billion in debt, giving a net cash position of 119.23 billion or 9,450.86 per share.

Cash & Cash Equivalents	334.27B
Total Debt	215.04B
Net Cash	119.23B
Net Cash Per Share	9,450.86
Equity (Book Value)	895.59B
Book Value Per Share	70,784.76
Working Capital	596.71B

Cash Flow

In the last 12 months, operating cash flow was 185.24 billion and capital expenditures -40.87 billion, giving a free cash flow of 144.37 billion.

Operating Cash Flow	185.24B
Capital Expenditures	-40.87B
Free Cash Flow	144.37B
FCF Per Share	11,443.16

Margins

Gross margin is 37.87%, with operating and profit margins of 12.36% and 11.28%.

Gross Margin	37.87%
Operating Margin	12.36%
Pretax Margin	12.46%
Profit Margin	11.28%
EBITDA Margin	14.61%
EBIT Margin	12.36%
FCF Margin	8.62%

Dividends & Yields

This stock pays an annual dividend of 1,047.62, which amounts to a dividend yield of 1.16%.

Dividend Per Share	1,047.62
Dividend Yield	1.16%
Dividend Growth (YoY)	15.50%
Years of Dividend Growth	6
Payout Ratio	7.05%
Buyback Yield	0.39%
Shareholder Yield	1.55%
Earnings Yield	16.45%
FCF Yield	12.62%

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.05

Scores

Chong Kun Dang Pharmaceutical has an Altman Z-Score of 4.22.

Altman Z-Score	4.22
Piotroski F-Score	n/a